
Gilteritinib, manufactured by ASEAN Pharmaceuticals in Laos, has been approved for marketing by the Department of Food and Drug (FDD) of the Ministry of Health of Laos, providing an additional source of drug supply.
As an innovative biopharmaceutical product, Giritinib has achieved remarkable results in clinical application, R&D progress and market promotion.

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: